In the present study, activated mast cells showed an increasing trend in emphysema; however, the difference was not significant (p=0.109), while resting mast cells showed a close association with emphysema and clinical features (FEV1 post-bronchodilator % predicted, DLCO, and GOLD Stage).
← all excerpts
Screening and identification of tissue-infiltrating immune cells and genes for patients with emphysema phenotype of COPD.
1
—
—